Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on April 21, 2025
LIPOZEM REVIEWS: How Reliable Is It? Investigation Completed 2025
GlobeNewswire
·
April 21, 2025
ST. PETERSBURG, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- Lipozem is an all-natural dietary supplement that uses only safe and natural components to promote healthy weight loss. With health and wellness taking center stage on a worldwide scale, there is a …
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine
GlobeNewswire
·
April 21, 2025
ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission to FDA Planned for June 2025 SEATTLE and VANCOUVER, …
Mindpeak and DigitCells Forge Alliance to Advance AI-Powered Digital Pathology Workflows: A Paradigm Shift for Diagnostic Precision and Efficiency
GlobeNewswire
·
April 21, 2025
Chicago, IL, April 21, 2025 (GLOBE NEWSWIRE) -- DigitCells, an innovator at the forefront of comprehensive pathology solutions, and Mindpeak, a pioneering force in artificial intelligence-driven pathology software, today announced a partnership. This …
Oregon Institute of Technology Announces Aspirations for a New Public College of Osteopathic Medicine
GlobeNewswire
·
April 21, 2025
Klamath Falls, Ore., April 21, 2025 (GLOBE NEWSWIRE) -- Oregon Institute of Technology (“OIT” or “Oregon Tech”) announced today its aspirations to establish a new College of Osteopathic Medicine designed to address the critical healthcare provider shortage …
Kham's House From Grief to Grace: One Mother’s Mission to Support Young Cancer Warriors Now Celebrates Three Years of Hope
GlobeNewswire
·
April 21, 2025
Dallas, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Kham’s House announces its 3-year anniversary celebration, unveiling an expanded slate of services for adolescents and young adults (AYAs) facing cancer and life-altering illnesses. Founded by Kischa Dawson- …
Hapbee Technologies Launching Highly Anticipated ‘Boosted Signals’ Feature with Upcoming New App Release
GlobeNewswire
·
April 21, 2025
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF | FSE: HA1), a digital wellness technology company, today announced the upcoming rollout of a significant new feature—Boosted Signals—as …
Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts
GlobeNewswire
·
April 21, 2025
Vancouver, Canada, April 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Senti Bio Participates in a Virtual Investor KOL Connect Segment
GlobeNewswire
·
April 21, 2025
Moderated discussion with Stephen Strickland, MD, MSCI, internationally respected leukemia researcher, Director of Leukemia Research for Sarah Cannon Research Institute and Kanya Rajangam, MD, PhD, President, Head of R…
PathAI Announces Poster Presentations at the 2025 American Association of Cancer Research Annual Meeting
GlobeNewswire
·
April 21, 2025
BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI's pathology universal transformer (PLUTO) foundation model and portfolio of oncology …
Eascra Biotech Receives U.S. National Science Foundation Grant
GlobeNewswire
·
April 21, 2025
BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech announced today that they have been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $274,990 to conduct research and development (R…
Vaccinex to Report Promising New Clinical Data Revealing Pepinemab’s Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)
GlobeNewswire
·
April 21, 2025
Neoadjuvant treatment with pepinemab appears to induce abundant, mature lymphoid structures that correlate with durable clinical benefit of immunotherapy in patients with metastatic melanoma. Pepinemab, Semaphorin 4D blocking immunotherapy, also appears to …
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
GlobeNewswire
·
April 21, 2025
Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia Patent Enables Equivalent Efficacy with 10 times Lower Energy Consumption Than Current Device Fully Compatible with Standard Implantable Pulse Generators, Enabling …
AP Bioscience to Present New Preclinical Data at American Association of Cancer Research Annual Meeting
GlobeNewswire
·
April 21, 2025
TAIPEI, Taiwan, April 21, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical abstract in …
Enlivex Announces Completion of Enrollment In The Phase II stage Of Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis
GlobeNewswire
·
April 21, 2025
Nes-Ziona, Israel, April 21, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Company completed enrollment of all patients in the …
HCI Group Sets 2025 Annual Shareholders Meeting and Record Date
GlobeNewswire
·
April 21, 2025
TAMPA, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE: HCI) will hold its Annual Meeting of Shareholders on Tuesday, June 10, 2025, at 3:00 p.m. Eastern time in the 1st Floor Auditorium of HCI’s headquarters at 3802 Coconut Palm Drive, …
Sofwave’s SUPERB™ Non-Invasive Skin Treatment Technology Receives Regulatory Clearance in Japan Significantly Expanding its Coverage of the APAC Region
GlobeNewswire
·
April 21, 2025
SAN CLEMENTE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Japan’s Pharmaceuticals and Medical Devices Agency ( …
IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
April 21, 2025
Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 following alignment on protocol with FDA LAWRENCEVILLE, N. …
Compass Therapeutics Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer
GlobeNewswire
·
April 21, 2025
BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, announced the first patient has been dosed in an …
Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025
GlobeNewswire
·
April 21, 2025
ST. LOUIS, April 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced today it will host a live demonstration of the GenesisX Robotic System at …
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
GlobeNewswire
·
April 21, 2025
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive …